Form 8-K - Current report:
SEC Accession No. 0001193125-19-067204
Filing Date
2019-03-07
Accepted
2019-03-07 16:11:33
Documents
2
Period of Report
2019-03-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d710927d8k.htm 8-K 16226
2 EX-99.1 d710927dex991.htm EX-99.1 60123
  Complete submission text file 0001193125-19-067204.txt   77525
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 19665968
SIC: 2834 Pharmaceutical Preparations